Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by Crossref.
DICKERSON, WILLARD W.
1942.
THE PRESENT STATUS OF DILANTIN THERAPY.
American Journal of Psychiatry,
Vol. 98,
Issue. 4,
p.
515.
Chaiken, Bernard H.
Goldberg, Bernard I.
and
Segal, Jack P.
1950.
Dilantin Sensitivity.
New England Journal of Medicine,
Vol. 242,
Issue. 23,
p.
897.
Tichner, Jerome B.
and
Enselberg, Charles D.
1951.
Suicidal Dilantin (Sodium Diphenylhydantoin) Poisoning.
New England Journal of Medicine,
Vol. 245,
Issue. 19,
p.
723.
Livingston, Samuel
1956.
Treatment of Epilepsy With Diphenylhydantoin Sodium.
Postgraduate Medicine,
Vol. 20,
Issue. 6,
p.
584.
Livingston, Samuel
1957.
Drug therapy for childhood epilepsy.
Journal of Chronic Diseases,
Vol. 6,
Issue. 1,
p.
46.
Dutton, Peter
1958.
Phenytoin Toxicity with Associated Meningeal Reaction.
Journal of Mental Science,
Vol. 104,
Issue. 437,
p.
1165.
Dreyer, Rudolf
1960.
Klinische Psychiatrie.
p.
778.
Patel, H.
and
Crichton, J.U.
1968.
The neurologic hazards ofdiphenylhydantoin in childhood.
The Journal of Pediatrics,
Vol. 73,
Issue. 5,
p.
676.
Barber, S G
1974.
Iatrogenic Stevens-Johnson Syndrome and Phenytoin.
Journal of International Medical Research,
Vol. 2,
Issue. 5,
p.
374.
Iivanainen, M.
Viukari, M.
and
Helle, E.‐P.
1977.
Cerebellar Atrophy in Phenytoin‐Treated Mentally Retarded Epileptics.
Epilepsia,
Vol. 18,
Issue. 3,
p.
375.
Wyte, Collette D
and
Berk, William A
1991.
Severe oral phenytoin overdose does not cause cardiovascular morbidity.
Annals of Emergency Medicine,
Vol. 20,
Issue. 5,
p.
508.
Keppel Hesselink, Jan M.
and
Kopsky, David J.
2017.
Phenytoin: 80 years young, from epilepsy to breast cancer, a remarkable molecule with multiple modes of action.
Journal of Neurology,
Vol. 264,
Issue. 8,
p.
1617.
eLetters
No eLetters have been published for this article.